Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes...

Area of Science:

• Immunology
• Endocrinology
• Diabetology

Background:

• Type 1 diabetes involves T-cell destruction of pancreatic beta-cells, with islet epitope-specific CD8(+) T-cells playing a key role.
• Monitoring these T-cells is crucial for assessing type 1 diabetes activity, progression, and treatment efficacy.
• Existing methods like ELISPOT and HLA tetramers are often insensitive and require large cell numbers.

Purpose of the Study:

• To develop and evaluate a novel technique for simultaneously monitoring multiple islet-specific CD8(+) T-cells.
• To assess the utility of this technique in patients with recent-onset type 1 diabetes, their relatives, and transplant recipients.

Main Methods:

• Utilized a combinatorial quantum dot major histocompatibility complex multimer technique.
• Simultaneously monitored HLA-A2 restricted CD8(+) T-cells specific for insulin B(10-18), prepro-insulin (PPI)(15-24), islet antigen (IA)-2(797-805), GAD65(114-123), islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)(265-273), and prepro islet amyloid polypeptide (ppIAPP)(5-13).
• Applied the developed 'Diab-Q-kit' to samples from recent-onset diabetic patients, siblings, healthy controls, and islet cell transplantation recipients.

Main Results:

• Islet autoreactive CD8(+) T-cells recognizing insulin B(10-18), IA-2(797-805), and IGRP(265-273) were frequently detected in recent-onset diabetic patients, but rarely in healthy controls.
• The PPI(15-24) epitope proved to be the most sensitive marker.
• The 'Diab-Q-kit' detected changes in autoreactive T-cell frequencies against multiple epitopes in islet cell transplantation recipients, correlating with disease activity and clinical outcomes.

Conclusions:

• A novel kit ('Diab-Q-kit') enables simultaneous detection of CD8(+) T-cells reactive to multiple HLA-A2-restricted beta-cell epitopes.
• This method requires only small blood volumes and does not necessitate in vitro culture.
• The kit is applicable to stored blood samples, facilitating retrospective and prospective studies in type 1 diabetes research.